Salspera
SciencePipelineOur DataTeamNews & PublicationsFAQContact
  1. FAQ
  2. ›
  3. Clinical trials

Is the full Saltikva Phase 2 dataset available for diligence?

The full dataset is not public. Qualified investors and partners can request data-room access under a confidentiality agreement through the contact form.

Still have a question?Contact us →
  • Batist et al., Cancer Immunol Immunother 2026;75(2):60 ↗
  • ClinicalTrials.gov NCT04589234 (Phase 2) ↗
All questions in this categoryAll 65 questions
SalsperaA privately held, privately funded biopharma company developing Saltikva® and a pipeline of microbial immunotherapies for solid tumors.
CompanyScienceOur DataPipelineTeam
UpdatesNews & PublicationsFAQContactmedia@salspera.com
Legal© 2026 Salspera, Inc. All rights reserved. Saltikva® is a registered trademark of Salspera, Inc. Saltikva® is an investigational therapy and has not been approved by any regulatory authority. Clinical results are from a single-arm, non-randomized study. Statements about future plans are forward-looking.